New Delhi: Revised maximum retail prices (MRPs) of 1,364 anti-cancer medicine formulations covering 121 drugs came into effect across India on Monday, November 9. The price changes are expected to result in annual savings of approximately Rs 3,540.38 crore for consumers.
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers, has capped trade margins on the MRPs of 137 anti-cancer drugs. The decision follows recommendations made by an Expert Committee constituted by the Directorate General of Health Services (DGHS) on October 17, 2026.
According to the ministry, 85 pharmaceutical companies had reported revised MRPs for 1,364 formulations as of November 8. Among these, 679 brands reported price reductions of more than 50 per cent. The highest reported reduction stands at 96.45 per cent.
The revised prices are intended to make cancer medicines more affordable and ease the financial pressure on patients and their families.
How Can Consumers Check Revised Cancer Drug Prices?
Consumers can check the updated MRP printed on medicine packs. They can also verify the prices through the Pharma Sahi Daam mobile application or the official NPPA website.
The authority has clarified that no chemist or hospital pharmacy is permitted to charge more than the revised MRP.
Where Can Patients Complain About Overcharging?
Consumers who are charged above the revised MRP or face other medicine pricing-related issues can register complaints through the Pharma Jan Samadhan portal.
They can also contact the NPPA helpline at 1800-111-255 to report grievances.
